NHS-Modified MMAF

Names

[ Name ]:
NHS-Modified MMAF

Biological Activity

[Description]:

NHS-Modified MMAF (WO2012143499A2, intermediat 210) is an intermediate which can be used for producing the anti-mesothelin binder-drug conjugates (ADCs)[1].

[Related Catalog]:

Research Areas >> Others

Signaling Pathways >> Others >> Others

[References]

[1]. Lerchen HG, et, al. Novel binder-drug conjugates (adcs) and their use. WO2012143499A2.

Chemical & Physical Properties

[ Molecular Formula ]:
C₅₅H₈₆N₈O₁₂

[ Molecular Weight ]:
1051.32

Related Compounds

NHS-MMAF
MC-Alkyl-Hydrazine Modified MMAF
Modified MMAF-C5-COOH
Modified MMAF
Bis(2,5-dioxopyrrolidin-1-yl) (disulfanediylbis(ethane-2,1-diyl)) dicarbonate
NHS-SS-Ac
3-[5-[3-[2-[2-(2-Aminoethoxy)ethoxy]ethoxy]propyl]-1-oxo-isoindolin-2-yl]piperidine-2,6-dione
3-(2-Chloro-1,3-thiazol-5-yl)-5-(propan-2-yl)-1,2-oxazole-4-carboxylic acid
3-(4-Methyl-1,3-thiazol-5-yl)-5-(propan-2-yl)-1,2-oxazole-4-carboxylic acid
4-((3-(Azetidin-3-ylmethyl)-4H-1,2,4-triazol-4-yl)methyl)pyridine
3-(2-Methylfuran-3-yl)-5-(propan-2-yl)-1,2-oxazole-4-carboxylic acid
5-Propyl-3-(pyridin-2-yl)-1,2-oxazole-4-carboxylic acid
3-(3-Methylthiophen-2-yl)-5-propyl-1,2-oxazole-4-carboxylic acid
5-propyl-3-(1H-pyrrol-2-yl)-1,2-oxazole-4-carboxylic acid
2-[4-(Propan-2-yl)phenyl]prop-2-en-1-amine
3,3-difluoro-2-[4-(1H-pyrazol-1-yl)phenyl]propan-1-amine